REG - CVS Group plc - Block Listing Application

CVSAnnouncement

22/12/2023 08:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231222:nRSV7588Xa&default-theme=true

RNS Number : 7588X  CVS Group plc  22 December 2023

22 December 2023

 

CVS Group plc

 

("CVS" or the "Company")

 

Block Listing Application

 

CVS, one of the UK's leading providers of integrated veterinary services,
announces that applications have been made to the London Stock Exchange for
the admission of 410,000 of its ordinary shares of 0.2p each in the Company
("Ordinary Shares") to trading on AIM.

 

The 410,000 Ordinary Shares will be reserved under block listings with 350,000
Ordinary Shares to be added to the preexisting CVS Group SAYE Plan block
listing and are to be issued in connection with the exercise of option awards
under the terms of the Company's SAYE Plan.

The remaining 60,000 Ordinary Shares are to be added to the preexisting CVS
Long Term Incentive Plan block listing and are to be issued in connection with
the grant, vesting and/or exercise of awards under the terms of the Company's
Long Term Incentive Plan ("LTIP").

When issued, the Ordinary Shares under the block listing will rank pari passu
with the Company's existing issued Ordinary Shares. It is anticipated that the
block-listed shares will be admitted on 28 December 2023.

 

Contacts:

CVS Group
plc
via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser &
Broker)
+44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

   Berenberg (Joint
Broker)
+44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial
PR)

Geoffrey
Pelham-Lane
                     +44 (0)7733 124 226

Ginny
Pulbrook
                                 +44 (0)7961
315 138

 

About CVS Group plc (www.cvsukltd.co.uk (http://www.cvsukltd.co.uk/) )

CVS Group is an AIM-listed provider of veterinary services in the UK,
Australia, the Netherlands and the Republic of Ireland.  CVS is focused on
providing high quality clinical services to its clients and their animals,
with outstanding and dedicated clinical teams and support colleagues at the
core of its strategy.

 

The Group has c.500 veterinary practices across its four markets, including
nine specialist referral hospitals and 39 dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties), Crematoria
(providing pet cremation and clinical waste disposal for CVS and third-party
practices), Buying Groups and the Group's online retail business ("Animed
Direct").

 

 The Group employs c.9,000 personnel, including c.2,400 veterinary surgeons
and c.3,300 nurses.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ALSPPGQCPUPWUMP